Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Enliven Therapeutics
ELVN
$3.92B
| $5.4M | ﹤0.01% |
231,234
+72,199
| +45% | +$1.52M |
|
2327
Carriage Services
CSV
$641M
| $5.4M | ﹤0.01% |
201,286
-24,254
| -11% | -$636K |
|
2328
Anterix
ATEX
$1.81B
| $5.4M | ﹤0.01% |
136,374
-713
| -0.5% | -$23.1K |
|
2329
Community Trust Bancorp
CTBI
$1.42B
| $5.39M | ﹤0.01% |
123,458
+1,670
| +1% | +$70.2K |
|
|
IAS
2330
DELISTED
Integral Ad Science
IAS
| $5.39M | ﹤0.01% |
554,379
+20,380
| +4% | +$195K |
|
|
ALX
2331
Alexander's
ALX
$1.3B
| $5.38M | ﹤0.01% |
23,917
+4,051
| +20% | +$873K |
|
2332
FIGS
FIGS
$1.79B
| $5.37M | ﹤0.01% |
1,007,055
+24,815
| +3% | +$127K |
|
2333
Sony
SONY
$137B
| $5.36M | ﹤0.01% |
315,690
+67,990
| +27% | +$1.12M |
|
2334
Relay Therapeutics
RLAY
$4.1B
| $5.36M | ﹤0.01% |
821,391
-90,766
| -10% | -$620K |
|
2335
Adtran
ADTN
$689M
| $5.35M | ﹤0.01% |
1,016,458
-123,804
| -11% | -$631K |
|
|
ETNB
2336
DELISTED
89bio
ETNB
| $5.34M | ﹤0.01% |
667,118
+37,885
| +6% | +$338K |
|
2337
Gogo Inc
GOGO
$565M
| $5.33M | ﹤0.01% |
554,551
+21,630
| +4% | +$205K |
|
2338
Universal Insurance Holdings
UVE
$1.22B
| $5.32M | ﹤0.01% |
283,813
-60,471
| -18% | -$1.18M |
|
2339
Republic Bancorp
RBCAA
$1.95B
| $5.29M | ﹤0.01% |
98,696
+717
| +0.7% | +$36.5K |
|
2340
Fulgent Genetics
FLGT
$470M
| $5.28M | ﹤0.01% |
269,256
-25,684
| -9% | -$536K |
|
2341
Hertz
HTZ
$499M
| $5.28M | ﹤0.01% |
1,495,714
+502,129
| +51% | +$2.55M |
|
2342
Kearny Financial
KRNY
$604M
| $5.27M | ﹤0.01% |
856,403
-103,465
| -11% | -$592K |
|
2343
Ubiquiti
UI
$33.7B
| $5.27M | ﹤0.01% |
36,153
-332
| -0.9% | -$42.6K |
|
|
HA
2344
DELISTED
Hawaiian Holdings, Inc.
HA
| $5.22M | ﹤0.01% |
419,612
+4,178
| +1% | +$54.6K |
|
|
DENN
2345
DELISTED
Denny's
DENN
| $5.18M | ﹤0.01% |
729,970
-98,355
| -12% | -$758K |
|
2346
Sanofi
SNY
$103B
| $5.16M | ﹤0.01% |
106,400
+36,344
| +52% | +$1.75M |
|
2347
Sana Biotechnology
SANA
$871M
| $5.15M | ﹤0.01% |
942,464
+118,954
| +14% | +$948K |
|
2348
Lufax Holding
LU
$1.35B
| $5.14M | ﹤0.01% |
2,166,847
+365,037
| +20% | +$1.39M |
|
2349
Castle Biosciences
CSTL
$855M
| $5.12M | ﹤0.01% |
235,344
+30,407
| +15% | +$678K |
|
2350
Cytek Biosciences
CTKB
$545M
| $5.12M | ﹤0.01% |
917,835
+16,842
| +2% | +$101K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.